Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Bilgi İşlem Daire Başkanlığı
Meü
Eczacılık Farmakoloji Doktora Programı
Son İki Yılda Uluslararası Dergilerde Yayınlanan Makaleler
2025
10. Tunçtan, B.; Elosman, M.; ÅŸenol, Å.; Ikiz, E.; Kara, T. RIPK1/RIPK3/MLKL necrosome contributes to the sepsis-induced cardiorenal necroptotic inflammatory injury and mortality. CURRENT MOLECULAR PHARMACOLOGY, 2025, 17, 1-16.
10.2174/0118761429374574250415114715
9. Naycı, S. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry. RESPIRATORY MEDICINE, 2025, 236, -.
8. Elosman, M.; ÅŸenol, Å.; Ikiz, E.; Tunçtan, B. Urotensin-II receptor contributes to the pro-inflammatory TLR4/MyD88/NF-κB/iNOS/NO pathway-mediated cardiovascular response to systemic lipopolysaccharide challenge in a septic shock model in rats. CELLULAR AND MOLECULAR BIOLOGY, 2025, 71, -.
2024
7. Sabrıe, Z.; Temiz reşitoğlu, M.; Kalkan, T.; Kılıç, B.; Tunçtan, B.; Malık, K.; şahan fırat, S. Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/ NF-κB activation. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2024, 175, 15-.
6. çerçi koçar, Ä.; özcan, P.; Koç, Z.; Süle, M.; Akbay, E.; Gen, R.; Sezer, K. Retrospective analysis of thyroid incidentalomas detected by [68Ga] Ga-PSMA-11 PET/CT. ENDOCRINE, 2024, 86, 302-309.
5. Kurt, S.; ÅŸenol, Å.; Küçük, D.; Bahçeli, Ã.; özgen, B.; Sabrıe, Z.; Ahmed-reda elosman, M.; Tunçtan, B. Inhibition of RIPK1-driven necroptosis ameliorates inflammatory hyperalgesia caused by lipopolysaccharide: involvement of TLR-, NLRP3-, and caspase-11- mediated signaling pathways. CELLULAR AND MOLECULAR BIOLOGY, 2024, 70, 52-58.
4. Sabrie, Z.; Temiz reşitoğlu, M.; Kalkan, T.; Kılıç, B.; Tunçtan, B.; Malik, K.; şahan fırat, S. Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/NF-κB activation. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2024, 175, -.
3. Polat yuluğ, D.; öztürk, B.; Baydar toprak, O.; öztürk, E.; Köktürk, N.; Naycı, S. Physicians’ irrational attitudes on the antibiotic prescribing for the treatment of COVID-19 in Turkey: A multicenter survey. BMC HEALTH SERVICES RESEARCH, 2024, 24, -.
2. Naycı, S. Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled?.. THE JOURNAL OF ASTHMA, 2024, 61, -.
1. Sabrıe, Z.; Temiz reşitoğlu, M.; Kalkan, T.; Kılıç, B.; Tunçtan, B.; Malık, K.; şahan fırat, S. Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/NF-κB activation. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2024, , -.
